“These synthetic insulin drugs, which today cost the manufacturers less than $2 to produce and were originally priced at $20 when released in the late 1990s, now range between $300 and $700.”
Texas Attorney General Sues Big Pharma Drug Manufacturers and PBMs
“[The lawsuit alleges that] the manufacturers artificially and willingly raised the prices of insulin then paid a significant, undisclosed portion back to the PBMs as a quid pro quo for inclusion in the PBMs’ standard offerings.
The PBMs then granted preferred status to the manufacturer whose drug has the highest list price while excluding lower priced drugs. These synthetic insulin drugs, which today cost the manufacturers less than $2 to produce and were originally priced at $20 when released in the late 1990s, now range between $300 and $700.” [State of Texas v. Eli Lilly et al., No. D-1-GN-24-007940 (Travis Ct. Tex. complaint filed Oct. 3, 2024)] MORE >>
Texas Attorney General Ken Paxton
